Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 3Phase NA 2Phase 3 2Phase 2/3 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Stomatitis 1Pain 1Mucositis 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Diphenhydramine × Clear all
NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Ohio State University Comprehensive Cancer Center

Phase 2/3 Completed
130 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT01837446 2013-04-23

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

Isfahan University of Medical Sciences

Phase 2/3 Completed
30 enrolled
Other

Pain, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡